Photo of Maha Hussain from pcf.org
Aug 10, 2024, 14:33
Importance of early genetic testing for prostate cancer patients
Kenrick Ng, Consultant in Medical Oncology at Barts Health NHS Trust, shared on X about a recent paper by Maha Hussain et al. titled “Abiraterone, Olaparib, or Abiraterone + Olaparib in First-line Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects (BRCAAway)” published in Clinical Cancer Research.
Authors: Maha Hussain et al.
“The most impactful piece in PCa from GU24 now published in full. Strong evidence that olap+abi combination is > than sequential treatment. Highlights importance of early genetic testing for prostate cancer patients.”
Source: Kenrick Ng/X
abiraterone
Arul Chinnaiyan
Barts Health NHS Trust
cancer
Channing Paller
Clinical Cancer Research
Daniel Shevrin
Emmanuel Antonarakis
GU24
Jingsong Zhang
Joel Picus
Kenrick Ng
Latifa Bazzi
Maha Hussain
Masha Kocherginsky
Matthew Rettig
Nabil Adra
Neeraj Agarwal
olaparib
olaparib + abiraterone
OncoDaily
Oncology
Robert Dreicer
Russell Szmulewitz
Ryan Stephenson
Scott Tagawa
Stephanie Daignault-Newton
Timothy Kuzel
Travis Gerke
Young Whang
Zachery Reichert
Aug 10, 2024, 14:21